Publications by authors named "Irwin Walker"

Claim this Profile
R
Real-world experience and outcomes of decitabine/cedazuridine or azacitidine for the treatment of myelodysplastic syndrome/chronic myelomonocytic leukemia.
Brittany Salter, Sarah Ge, Alejandro Garcia-Horton, Tobias Berg, Brian Leber, Irwin Walker

Leuk Lymphoma· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of expanding allogeneic stem cell transplantation on survival in acute myeloid leukemia: a population-based study.
Brittany Salter, Alejandro Garcia-Horton, Irwin Walker, Brian Leber, Kylie Lepic

Blood Cancer J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Nazanin Aghel, Vincent Wang, Darryl Leong, Michelle Lui, Livia Fu, Irwin Walker

JACC Adv· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS.
Michael Radford, Alejandro Garcia-Horton, Rohail Badami, Elaine Jin, Nida Usmani, Irwin Walker

Transplant Cell Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma.
Shiliang Ge, Kylie Lepic, Ravi Bhindi, Tobias Berg, Dina Khalaf, Irwin Walker

Curr Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
Naveen Pemmaraju, Eric Deconinck, Priyanka Mehta, Irwin Walker, Marco Herling

Clin Lymphoma Myeloma Leuk· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
Dennis Dong Hwan Kim, Gizelle Popradi, Kylie Lepic, Kristjan Paulson, David Allan, Irwin Walker

Curr Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells.
Mackenzie Bowman, Lara Casey, Soundarya N Selvam, Patricia D A Lima, Orla Rawley, Irwin Walker

J Thromb Haemost· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia.
Denis Claude Roy, Irwin Walker, Johan Maertens, Philippe Lewalle, Eduardo Olavarria

Leukemia· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel.
Francesca Bonifazi, Marie-Thérèse Rubio, Andrea Bacigalupo, Jaap Jan Boelens, Jürgen Finke, Irwin Walker

Bone Marrow Transplant· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liberal Versus Restrictive Red Blood Cell Transfusion Thresholds in Hematopoietic Cell Transplantation: A Randomized, Open Label, Phase III, Noninferiority Trial.
Jason Tay, David S Allan, Elizabeth Chatelain, Doug Coyle, Mohamed Elemary, Irwin Walker

J Clin Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis - Authors' reply.
Irwin Walker, Tony Panzarella, Gizelle Popradi

Lancet Haematol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Thymocyte Globulin Prophylaxis Induces a Decrease in Naive Th Cells to Inhibit the Onset of Chronic Graft-versus-Host Disease: Results from the Canadian Bone Marrow Transplant Group (CBMTG) 0801 Study.
Leonie Naeije, Amina Kariminia, Sayeh Abdossamadi, Shima Azadpour, Peter Subrt, Irwin Walker

Biol Blood Marrow Transplant· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
Irwin Walker, Tony Panzarella, Stephen Couban, Felix Couture, Gerald Devins

Lancet Haematol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline.
Joseph Mikhael, Nofisat Ismaila, Matthew C Cheung, Caitlin Costello, Madhav V Dhodapkar, Irwin Walker

J Clin Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher levels of free plasma mitochondrial DNA are associated with the onset of chronic GvHD.
Jacob Rozmus, Sabine Ivison, Amina Kariminia, Vivian M Leung, Susanna Sung, Irwin Walker

Bone Marrow Transplant· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era.
Mary Lynn Savoie, Isabelle Bence-Bruckler, Lothar B Huebsch, Marc Lalancette, Chris Hillis, Irwin Walker

Leuk Res· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD56 natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft--host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results.
Amina Kariminia, Sabine Ivison, Bernard Ng, Jacob Rozmus, Susanna Sung, Irwin Walker

Haematologica· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study" [Biol Blood Marrow Transplant 2016;22:1410-1415].
Stephen Couban, Mahmoud Aljurf, Sylvie Lachance, Irwin Walker, Cynthia Toze

Biol Blood Marrow Transplant· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.
Frederick L Locke, Joseph Pidala, Barry Storer, Paul J Martin, Michael A Pulsipher, Irwin Walker

Biol Blood Marrow Transplant· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study.
Stephen Couban, Mahmoud Aljurf, Sylvie Lachance, Irwin Walker, Cynthia Toze

Biol Blood Marrow Transplant· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells.
Amina Kariminia, Shernan G Holtan, Sabine Ivison, Jacob Rozmus, Marie-Josée Hebert, Irwin Walker

Blood· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial.
Irwin Walker, Tony Panzarella, Stephen Couban, Felix Couture, Gerald Devins

Lancet Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.
Paul J Martin, Stephanie J Lee, Donna Przepiorka, Mary M Horowitz, John Koreth, Irwin Walker

Biol Blood Marrow Transplant· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The haemophilia certification system in Canada.
Davide Matino, Jerry Teitel, David Page, Arun Keepanasseril, Alfonso Iorio, Irwin Walker

Blood Transfus· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis